Cardiovascular risks with azithromycin and other antibacterial drugs

New England Journal of Medicine

Volumn 368, Issue 18, 2013, Pages 1665-1668

  Mosholder, Andrew D ^a   Mathew, Justin ^a   Alexander, John J ^a   Smith, Harry ^a   Nambiar, Sumathi ^a  

^a Center for Drug Evaluation and Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIARRHYTHMIC AGENT; AZITHROMYCIN; CEFALEXIN; CEFDINIR; CEFUROXIME; CLARITHROMYCIN; COTRIMOXAZOLE; DOFETILIDE; DOXYCYCLINE; ERYTHROMYCIN; GREPAFLOXACIN; LEVOFLOXACIN; MACROLIDE; MAGNESIUM; MOXIFLOXACIN; PENICILLIN V; POTASSIUM; PROCAINAMIDE; QUINIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SOTALOL; UNCLASSIFIED DRUG; ZITHROMAX Z PAK;

BRADYCARDIA; BRONCHITIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC SINUSITIS; COMMUNITY ACQUIRED PNEUMONIA; DRUG CONTRAINDICATION; DRUG LABELING; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; MEDICAL DECISION MAKING; OBSERVATIONAL STUDY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QT PROLONGATION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SHORT SURVEY; SUDDEN CARDIAC DEATH; TORSADE DES POINTES; UNITED STATES;

EID: 84877267913     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1302726     Document Type: Article

References (5)

1. Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012;366:1881-90.
2. Asadi L, Eurich DT, Gamble JM, Minhas- Sandhu JK, Marrie TJ, Majumdar SR. Guideline adherence and macrolides reduced mortality in outpatients with pneumonia. Respir Med 2012;106:451-8.
3. Asadi L, Sligl WI, Eurich DT, et al. Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis. Clin Infect Dis 2012;55:371-80.
4. Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM. Oral erythromycin use and the risk of sudden cardiac death. N Engl J Med 2004;351:1089-96.
5. Lapi F, Wilchesky M, Kezouh A, Benisty JI, Ernst P, Suissa S. Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis 2012;55:1457-65.